Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker

ES Robinson, EV Khankin, SA Karumanchi… - Seminars in …, 2010 - Elsevier
Drugs that inhibit the vascular endothelial growth factor (VEGF) signaling pathway are a
rapidly growing chemotherapy class for treatment of solid tumors. This targeted therapy is …

Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: Mechanisms and potential use as a biomarker

ES Robinson, EV Khankin, SA Karumanchi… - Seminars in …, 2010 - profiles.wustl.edu
Drugs that inhibit the vascular endothelial growth factor (VEGF) signaling pathway are a
rapidly growing chemotherapy class for treatment of solid tumors. This targeted therapy is …

[引用][C] Hypertension Induced by Vascular Endothelial Growth Factor Signaling Pathway Inhibition: Mechanisms and Potential Use as a Biomarker

ES Robinson, EV Khankin, SA Karumanchi… - Seminars in …, 2010 - cir.nii.ac.jp
Hypertension Induced by Vascular Endothelial Growth Factor Signaling Pathway Inhibition:
Mechanisms and Potential Use as a Biomarker | CiNii Research CiNii 国立情報学研究所 学術 …

[HTML][HTML] Hypertension Induced by VEGF Signaling Pathway Inhibition: Mechanisms and Potential Use as a Biomarker

ES Robinson, EV Khankin, SA Karumanchi… - Seminars in …, 2010 - ncbi.nlm.nih.gov
Drugs that inhibit the vascular endothelial growth factor (VEGF) signaling pathway are a
rapidly growing chemotherapy class for treatment of solid tumors. This “targeted therapy” is …

Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker

ES Robinson, EV Khankin… - Seminars in …, 2010 - pubmed.ncbi.nlm.nih.gov
Drugs that inhibit the vascular endothelial growth factor (VEGF) signaling pathway are a
rapidly growing chemotherapy class for treatment of solid tumors. This targeted therapy is …

Hypertension Induced by Vascular Endothelial Growth Factor Signaling Pathway Inhibition: Mechanisms and Potential Use as a Biomarker

ES Robinson, EV Khankin, SA Karumanchi… - Seminars in …, 2010 - infona.pl
Drugs that inhibit the vascular endothelial growth factor (VEGF) signaling pathway are a
rapidly growing chemotherapy class for treatment of solid tumors. This targeted therapy is …

Hypertension Induced by Vascular Endothelial Growth Factor Signaling Pathway Inhibition: Mechanisms and Potential Use as a Biomarker

ES Robinson, EV Khankin… - Seminars in …, 2010 - seminarsinnephrology.org
Drugs that inhibit the vascular endothelial growth factor (VEGF) signaling pathway are a
rapidly growing chemotherapy class for treatment of solid tumors. This targeted therapy is …

Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker.

ES Robinson, EV Khankin, SA Karumanchi… - Seminars in …, 2010 - europepmc.org
Drugs that inhibit the vascular endothelial growth factor (VEGF) signaling pathway are a
rapidly growing chemotherapy class for treatment of solid tumors. This “targeted therapy” is …

[PDF][PDF] Hypertension Induced by VEGF Signaling Pathway Inhibition: Mechanisms and Potential Use as a Biomarker

ES Robinson - Semin Nephrol, 2010 - researchgate.net
Drugs that inhibit the vascular endothelial growth factor (VEGF) signaling pathway are a
rapidly growing chemotherapy class for treatment of solid tumors. This “targeted therapy” is …

Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker.

ES Robinson, EV Khankin, SA Karumanchi… - Seminars in …, 2010 - europepmc.org
Drugs that inhibit the vascular endothelial growth factor (VEGF) signaling pathway are a
rapidly growing chemotherapy class for treatment of solid tumors. This “targeted therapy” is …